Condensed Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Current assets:
Cash	$ 1,058	$ 1,115
Prepaid expenses and other current assets	91	22
Total current assets	1,149	1,137
Property and equipment, net		2
Other assets		33
Total assets	1,149	1,172
Current liabilities:
Accounts payable	772	788
Accrued compensation and employee benefits	15	73
Accrued clinical trial expenses	104	509
Other accrued liabilities	200	279
Total current liabilities	1,091	1,649
Commitments and contingencies
Stockholders' equity/(deficit):
Preferred stock, $0.01 par value, 15,000 shares authorized; No shares issued and outstanding
Common stock, $0.01 par value, 150,000 and 70,000 shares authorized; 41,420 and 26,545 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively	414	265
Additional paid-in capital	294,030	291,533
Accumulated deficit	(294,386)	(292,275)
Total stockholders' equity/(deficit)	58	(477)
Total liabilities and stockholders' equity/(deficit)	$ 1,149	$ 1,172